Detalhe da pesquisa
1.
Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron.
Nature
; 603(7902): 693-699, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35062016
2.
Coronaviruses exploit a host cysteine-aspartic protease for replication.
Nature
; 609(7928): 785-792, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35922005
3.
Type-II IFN inhibits SARS-CoV-2 replication in human lung epithelial cells and ex vivo human lung tissues through indoleamine 2,3-dioxygenase-mediated pathways.
J Med Virol
; 96(2): e29472, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38373201
4.
Low Environmental Temperature Exacerbates Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Golden Syrian Hamsters.
Clin Infect Dis
; 75(1): e1101-e1111, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34536277
5.
Attenuated Interferon and Proinflammatory Response in SARS-CoV-2-Infected Human Dendritic Cells Is Associated With Viral Antagonism of STAT1 Phosphorylation.
J Infect Dis
; 222(5): 734-745, 2020 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32563187
6.
Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19.
Clin Infect Dis
; 71(6): 1400-1409, 2020 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32270184
7.
Middle East respiratory syndrome coronavirus and bat coronavirus HKU9 both can utilize GRP78 for attachment onto host cells.
J Biol Chem
; 293(30): 11709-11726, 2018 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-29887526
8.
PAN substitutions A37S, A37S/I61T and A37S/V63I attenuate the replication of H7N7 influenza A virus by impairing the polymerase and endonuclease activities.
J Gen Virol
; 98(3): 364-373, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28113045
9.
Cross-protection of influenza A virus infection by a DNA aptamer targeting the PA endonuclease domain.
Antimicrob Agents Chemother
; 59(7): 4082-93, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25918143
10.
Divergent trajectory of replication and intrinsic pathogenicity of SARS-CoV-2 Omicron post-BA.2/5 subvariants in the upper and lower respiratory tract.
EBioMedicine
; 99: 104916, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38101297
11.
Vaccine-induced protection against SARS-CoV-2 requires IFN-γ-driven cellular immune response.
Nat Commun
; 14(1): 3440, 2023 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37301910
12.
Broad-spectrum humanized monoclonal neutralizing antibody against SARS-CoV-2 variants, including the Omicron variant.
Front Cell Infect Microbiol
; 13: 1213806, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37645378
13.
Altered host protease determinants for SARS-CoV-2 Omicron.
Sci Adv
; 9(3): eadd3867, 2023 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36662861
14.
A new generation Mpro inhibitor with potent activity against SARS-CoV-2 Omicron variants.
Signal Transduct Target Ther
; 8(1): 128, 2023 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36928316
15.
The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5.
EBioMedicine
; 95: 104753, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37579626
16.
hnRNP C modulates MERS-CoV and SARS-CoV-2 replication by governing the expression of a subset of circRNAs and cognitive mRNAs.
Emerg Microbes Infect
; 11(1): 519-531, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35060842
17.
Age-associated SARS-CoV-2 breakthrough infection and changes in immune response in a mouse model.
Emerg Microbes Infect
; 11(1): 368-383, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34989330
18.
Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2.
Emerg Microbes Infect
; 11(1): 2275-2287, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36039901
19.
Targeting ACLY efficiently inhibits SARS-CoV-2 replication.
Int J Biol Sci
; 18(12): 4714-4730, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35874959
20.
Virological features and pathogenicity of SARS-CoV-2 Omicron BA.2.
Cell Rep Med
; 3(9): 100743, 2022 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36084644